Authors:
MARTINAND C
SALEHZADA T
SILHOL M
LEBLEU B
BISBAL C
Citation: C. Martinand et al., RNASE-L INHIBITOR (RLI) ANTISENSE CONSTRUCTIONS BLOCK PARTIALLY THE DOWN-REGULATION OF THE 2-5A RNASE-L PATHWAY IN ENCEPHALOMYOCARDITIS-VIRUS-(EMCV)-INFECTED CELLS/, European journal of biochemistry, 254(2), 1998, pp. 248-255
Authors:
MANDL M
NOLOP K
LUTSKY BN
ALDREY O
ARKINSTALL W
BAILLIEAU R
BISBAL C
BRISCOE M
CABRAL J
CHANDRA R
CORREA O
DAY J
DAVIES R
DIBILDOX J
DOLOVICH J
DROUIN M
HEBERT J
LOPEZ J
MENDEZ R
OBERASCHER G
ROLAPLESZCZYNSKI M
ROULEAU M
STERN M
SUAREZ R
TERRAZA O
THOMSON D
TSE K
YANG W
Citation: M. Mandl et al., COMPARISON OF ONCE-DAILY MOMETASONE FUROATE (NASONEX) AND FLUTICASONEPROPIONATE AQUEOUS NASAL SPRAYS FOR THE TREATMENT OF PERENNIAL RHINITIS, Annals of allergy, asthma, & immunology, 79(3), 1997, pp. 237-245
Authors:
DIRIONG S
SALEHZADA T
BISBAL C
MARTINAND C
TAVIAUX S
Citation: S. Diriong et al., LOCALIZATION OF THE RIBONUCLEASE-L INHIBITOR GENE (RNS41), A NEW MEMBER OF THE INTERFERON-REGULATED 2-5A PATHWAY, TO 4Q31 BY FLUORESCENCE IN-SITU HYBRIDIZATION, Genomics, 32(3), 1996, pp. 488-490
Authors:
BISBAL C
MARTINAND C
SILHOL M
LEBLEU B
SALEHZADA T
Citation: C. Bisbal et al., CLONING AND CHARACTERIZATION OF A RNASE-L INHIBITOR - A NEW COMPONENTOF THE INTERFERON-REGULATED 2-5A PATHWAY, The Journal of biological chemistry, 270(22), 1995, pp. 13308-13317